The Effects and Safety of Diabetic GUideline Algorithm Implementation in the Community (GUARD-Community) study is a 2-arm, cluster-randomized control trial to evaluate the effect and safety of guideline algorithm intervention performed by primary care physicians on cardiovascular and renal outcomes in elderly patients with high risk in community.
①Males or females aged 65 and above (≥65) receive treatment from the local community health service center;
A. Typical symptoms of diabetes + random blood sugar ≥ 11.1mmol/L;
B. Fasting blood glucose (FPG) ≥ 7.0mmol/L (fasting blood glucose is defined as no caloric intake within 8 hours);
C. Oral glucose tolerance test 2h blood glucose (OGTT) ≥ 11.1mmol/L (2h after meal);
①Pregnant women or women planning to become pregnant;
②eGFR<30 mL/min/1.73m2 (CKD-EPI formula);
③Patient cannot be followed up for 36 months (due to health condition or migration);
④Unwilling or unable to sign the informed consent;